Saga, Teofila N.

HRN: 04-03-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/04/2026
07/10/2026
IV
2.25g
Q6
Septic Shock Sec To CAP-HR And UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines